BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sanwa Kagaku Kenkyusho readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Sanwa Kagaku Kenkyusho's drugs ru
 n\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07890584-905@assetmemo.bio
DTSTAMP:20261121T010845Z
DTSTART;VALUE=DATE:20320222
DTEND;VALUE=DATE:20320223
SUMMARY:UPASITA (Upacicalcet): Phase 3 readout est. (NCT07890584)
DESCRIPTION:UPASITA (Upacicalcet)\, phase 3\, Chronic Kidney Disease.\nStud
 y: A Study of PLS240 in Pediatric Participants With Secondary Hyperparathy
 roidism and Chronic Kidney Disease on Hemodialysis\nEstimated primary comp
 letion: 22 February 2032. This is a ClinicalTrials.gov estimate\, not a co
 nfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/
 drug/upacicalcet#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07890584
URL:https://assetmemo.bio/drug/upacicalcet#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
